Postigo Andrea, Bermejo Javier, Muñoz Patricia, Valerio Maricela, Marín Mercedes, Pinilla Blanca, Cuerpo Gregorio, Marí Amaia, Delgado-Montero Antonia, Bouza Emilio, Fernández-Avilés Francisco, Martínez-Sellés Manuel
Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Facultad de Medicina, Universidad Complutense, Madrid, Spain; CIBERCV, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Facultad de Medicina, Universidad Complutense, Madrid, Spain; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.
Int J Cardiol. 2020 May 15;307:82-86. doi: 10.1016/j.ijcard.2020.02.029. Epub 2020 Feb 12.
We sought to study the prevalence of cardiac troponin T (TnT) elevation in patients with infective endocarditis (IE) and its association with in-hospital outcomes.
Retrospective single-center study. From 2008 to 2018, 528 patients were diagnosed with IE and 250 (47.3%) had at least a TnT determination during hospital admission, 103 with conventional TnT assay and 147 with high-sensitive assay. Elevated TnT levels were found in 210 patients (84.0%). Compared with patients with normal TnT levels, patients with TnT elevation presented higher in-hospital mortality (5 [12.5%] vs. 77 [36.7%], p < 0.001) and more frequent complications: heart failure (9 [22.5%] vs. 106 [50.5%], p < 0.001), cardiac abscesses (4 [10.0%] vs 58 [27.6%], p = 0.03), conduction disorders (0 vs. 26 [12,4%]; p = 0.04), and involvement of the central nervous system (1 [2.5%] vs. 38 [18.1%];p = 0.02). Patients with elevated TnT had more frequent indication for surgery (24 [60.0%] vs. 179 [85.2%], p < 0.001) and were operated on more frequently (16 [40.0%] vs 123 [58.6%], p = 0.03). TnT elevation was an independent predictor of in-hospital mortality (OR 3.31; 95% CI 1.02-10.72, p = 0.05). Adding TnT data to conventional clinical models improved the predictive capability of in-hospital mortality (R: 0.407 vs. 0.388, χ: 85.03 vs. 80.40, p < 0.001), resulting in a net reclassification improvement of 0.29 (95% CI: 0.13-0.46, p < 0.01).
TnT elevation is very common in patients with IE and is associated with increased in-hospital mortality and complications, thus routine monitoring should be recommended.
我们旨在研究感染性心内膜炎(IE)患者中心肌肌钙蛋白T(TnT)升高的患病率及其与住院结局的关联。
回顾性单中心研究。2008年至2018年,528例患者被诊断为IE,其中250例(47.3%)在住院期间至少进行了一次TnT测定,103例采用传统TnT检测法,147例采用高敏检测法。210例患者(84.0%)TnT水平升高。与TnT水平正常的患者相比,TnT升高的患者住院死亡率更高(5例[12.5%]对77例[36.7%],p<0.001),并发症更常见:心力衰竭(9例[22.5%]对106例[50.5%],p<0.001)、心脏脓肿(4例[10.0%]对58例[27.6%],p=0.03)、传导障碍(0例对26例[12.4%];p=0.04)以及中枢神经系统受累(1例[2.5%]对38例[18.1%];p=0.02)。TnT升高的患者手术指征更常见(24例[60.0%]对179例[85.2%],p<0.001),手术频率更高(16例[40.0%]对123例[58.6%],p=0.03)。TnT升高是住院死亡率的独立预测因素(OR 3.31;95%CI 1.02-10.72,p=0.05)。将TnT数据添加到传统临床模型中可提高住院死亡率的预测能力(R:0.407对0.388,χ:85.03对80.40,p<0.001),净重新分类改善为0.29(95%CI:0.13-0.46,p<{0.01})。
TnT升高在IE患者中非常常见,且与住院死亡率和并发症增加相关;因此,建议进行常规监测。